Curing hepatocellular carcinomatosis with biologic therapy and surgery: Achieving the impossible?

Melanie B. Thomas; Eric Tetzlaff; Richard Lozano; Leigh Samp; Charles E. Butler; Christopher Gannon; Stanley Hamilton; Jean Nicholas Vauthey; Eddie Abdalla

doi:10.1002/jso.20898

Curing hepatocellular carcinomatosis with biologic therapy and surgery: Achieving the impossible?

Melanie B. Thomas, Eric Tetzlaff, Richard Lozano, Leigh Samp, Charles E. Butler, Christopher Gannon, Stanley Hamilton, Jean Nicholas Vauthey, Eddie Abdalla

Academic Institute

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Hepatocellular carcinoma (HCC) that present as hemoperitoneum are uncommon, often recur as peritoneal carcinomatosis, and have poor prognosis. Systemic chemotherapies are minimally effective in advanced HCC and less so as neo-adjuvant therapy. This report describes a 47-year woman with ruptured HCC who developed recurrent carcinomatosis. She received biologically targeted systemic therapy which resulted in significant radiographic tumor response. Salvage surgery revealed complete pathologic response in all tumor nodules, thus the patient was rendered cancer-free.

Original language	English (US)
Pages (from-to)	82-84
Number of pages	3
Journal	Journal of Surgical Oncology
Volume	97
Issue number	1
DOIs	https://doi.org/10.1002/jso.20898
State	Published - Jan 1 2008

Keywords

Hepatocellular carcinoma
Resection
Targeted chemotherapy

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1002/jso.20898

Cite this

@article{1f715a2bedcf4b0fb0f60246257eec94,

title = "Curing hepatocellular carcinomatosis with biologic therapy and surgery: Achieving the impossible?",

abstract = "Hepatocellular carcinoma (HCC) that present as hemoperitoneum are uncommon, often recur as peritoneal carcinomatosis, and have poor prognosis. Systemic chemotherapies are minimally effective in advanced HCC and less so as neo-adjuvant therapy. This report describes a 47-year woman with ruptured HCC who developed recurrent carcinomatosis. She received biologically targeted systemic therapy which resulted in significant radiographic tumor response. Salvage surgery revealed complete pathologic response in all tumor nodules, thus the patient was rendered cancer-free.",

keywords = "Hepatocellular carcinoma, Resection, Targeted chemotherapy",

author = "Thomas, {Melanie B.} and Eric Tetzlaff and Richard Lozano and Leigh Samp and Butler, {Charles E.} and Christopher Gannon and Stanley Hamilton and Vauthey, {Jean Nicholas} and Eddie Abdalla",

year = "2008",

month = jan,

day = "1",

doi = "10.1002/jso.20898",

language = "English (US)",

volume = "97",

pages = "82--84",

journal = "Journal of Surgical Oncology",

issn = "0022-4790",

publisher = "Wiley",

number = "1",

}

TY - JOUR

T1 - Curing hepatocellular carcinomatosis with biologic therapy and surgery

T2 - Achieving the impossible?

AU - Thomas, Melanie B.

AU - Tetzlaff, Eric

AU - Lozano, Richard

AU - Samp, Leigh

AU - Butler, Charles E.

AU - Gannon, Christopher

AU - Hamilton, Stanley

AU - Vauthey, Jean Nicholas

AU - Abdalla, Eddie

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Hepatocellular carcinoma (HCC) that present as hemoperitoneum are uncommon, often recur as peritoneal carcinomatosis, and have poor prognosis. Systemic chemotherapies are minimally effective in advanced HCC and less so as neo-adjuvant therapy. This report describes a 47-year woman with ruptured HCC who developed recurrent carcinomatosis. She received biologically targeted systemic therapy which resulted in significant radiographic tumor response. Salvage surgery revealed complete pathologic response in all tumor nodules, thus the patient was rendered cancer-free.

AB - Hepatocellular carcinoma (HCC) that present as hemoperitoneum are uncommon, often recur as peritoneal carcinomatosis, and have poor prognosis. Systemic chemotherapies are minimally effective in advanced HCC and less so as neo-adjuvant therapy. This report describes a 47-year woman with ruptured HCC who developed recurrent carcinomatosis. She received biologically targeted systemic therapy which resulted in significant radiographic tumor response. Salvage surgery revealed complete pathologic response in all tumor nodules, thus the patient was rendered cancer-free.

KW - Hepatocellular carcinoma

KW - Resection

KW - Targeted chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=38149053003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38149053003&partnerID=8YFLogxK

U2 - 10.1002/jso.20898

DO - 10.1002/jso.20898

M3 - Article

C2 - 17918216

AN - SCOPUS:38149053003

SN - 0022-4790

VL - 97

SP - 82

EP - 84

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

IS - 1

ER -

Curing hepatocellular carcinomatosis with biologic therapy and surgery: Achieving the impossible?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this